Validation Criteria | Level | Artemether-Lumefantrine | Artesunate-Amodiaquine | ||
Artemether | Lumefantrine | Artesunate | Amodiaquine | ||
Trueness: Absolute bias (µg/mL) (Relative bias (%)) | 1 | 1.76 (2.20) | −9.83 (−2.05) | 1.40 (1.74) | 0.79 (0.33) |
2 | 0.83 (0.69) | −42.54 (−5.91) | −0.97 (−0.81) | 0.33 (0.08) | |
3 | −4.34 (−2.71) | 36.58 (3.81) | −0.04 (−0.03) | 3.78 (0.79) | |
4 | −4.34 (−2.17) | 25.12 (2.09) | −4.76 (−2.38) | −2.71 (−0.45) | |
5 | 3.22 (1.34) | −44.56 (−3.18) | 1.77 (0.74) | 8.21 (−0.33) | |
Precision: Repeatability (RSD in %)/ Intermediate precision (RSD in %) | 1 | 3.28/3.28 | 0.56/0.77 | 3.29/3.29 | 3.24/3.24 |
2 | 2.04/2.37 | 0.44/0.67 | 0.80/0.80 | 1.28/1.28 | |
3 | 2.18/2.18 | 2.11/2.11 | 0.53/0.53 | 1.01/1.01 | |
4 | 1.24/1.24 | 1.81/1.81 | 1.19/1.24 | 1.08/1.08 | |
5 | 1.63/1.89 | 0.97/0.99 | 1.03/1.41 | 1.13/1.33 | |
Accuracy: β-expectation tolerance interval (in µg/mL) (Relative β-expectation tolerance interval (in %)) | 1 | 75.33 - 88.19 (−5.83/10.24) | 459.30 - 481.10 (−4.32/0.22) | 74.96 - 87.85 (−6.31/9.81) | 221.80 - 259.80 (−7.60/8.26) |
2 | 113.30 - 128.40 (−5.60/6.97) | 662.20 - 692.70 (−8.02/−3.80) | 116.70 - 121.40 (−2.76/1.14) | 349.10 - 371.50 (−3.04/3.21) | |
3 | 147.10 - 164.2 (−8.05/2.63) | 947.00 - 1046.00 (−1.35/8.97) | 157.90 - 162.00 (−1.32/1.27) | 471.90 - 495.60 (−1.68/3.26) | |
4 | 189.60 - 201.70 (−5.20/0.86) | 1172.00 - 1278.00 (−2.32/6.51) | 189.00 - 201.40 (−5.48/0.72) | 581.40 - 613.10 (−3.09/2.19) | |
5 | 231.2 - 255.2 (−3.67/6.35) | 1321.00 - 1390.00 (−5.64/−0.73) | 231.00 - 251.30 (−3.42/4.90) | 708.30 - 748.20 (−1.63/3.91) | |
Uncertainty: Relative expanded uncertainty (%) | 1 | 6.92 | 1.69 | 6.94 | 6.83 |
2 | 5.12 | 1.49 | 1.68 | 2.69 | |
3 | 4.60 | 4.45 | 1.12 | 2.13 | |
4 | 2.61 | 3.81 | 2.64 | 2.28 | |
5 | 4.09 | 2.10 | 3.10 | 2.39 | |
Linearity: | Slope | 0.994 | 1.002 | 0.992 | 1.010 |
Intercept | 0.329 | −8.938 | 0.703 | −2.659 | |
R2 | 0.994 | 0.988 | 0.997 | 0.998 |